Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

CEO

Dr. Iraj Ali Ph.D.

Pekerja

204

Negara

United Kingdom

ISIN

US00449L1026

Penyenaraian

698.MU

STU

698.STU

0 Comments

Kongsi pendapat anda

FAQ

Berapakah harga saham Achilles Therapeutics hari ini?▼

Harga semasa 698.MU ialah €1.36 EUR — telah meningkat sebanyak +0% dalam 24 jam yang lalu. Pantau prestasi harga saham Achilles Therapeutics dengan lebih dekat pada carta.

Apakah simbol saham Achilles Therapeutics?▼

Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa , saham Achilles Therapeutics didagangkan di bawah simbol 698.MU.

Berapa ramai pekerja yang dimiliki oleh Achilles Therapeutics?▼

Sehingga Mei 11, 2026, syarikat mempunyai 204 pekerja.

Achilles Therapeutics terletak dalam sektor apa?▼

Achilles Therapeutics beroperasi dalam sektor Lain-lain.

Bilakah Achilles Therapeutics menyiapkan split saham?▼

Achilles Therapeutics tidak mempunyai sebarang split baru-baru ini.

Di manakah ibu pejabat Achilles Therapeutics?▼

Ibu pejabat Achilles Therapeutics terletak di London, United Kingdom.